Attached files

file filename
EX-10.1 - EX-10.1 - USMD Holdings, Inc.d743406dex101.htm

 

 

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

 

 

FORM 8-K

 

 

CURRENT REPORT

PURSUANT TO SECTION 13 OR 15(d)

OF THE SECURITIES EXCHANGE ACT OF 1934

Date of Report (Date of earliest event reported): June 6, 2014

 

 

USMD Holdings, Inc.

(Exact name of registrant as specified in its charter)

 

 

 

Delaware   001-35639   27-2866866

(State

of incorporation)

 

(Commission

File Number)

 

(IRS Employer

Identification Number)

6333 North State Highway 161, Suite 200

Irving, Texas 75038

(Address of principal executive offices)

Registrant’s telephone number, including area code: (214) 493-4000

 

 

Check the appropriate box if the Form 8-K filing is intended to simultaneously satisfy the reporting obligation of the registrant under any of the following provisions:

 

¨ Written communications pursuant to Rule 425 under the Securities Act

 

¨ Soliciting material pursuant to Rule 14a-12 of the Exchange Act

 

¨ Pre-commencement communications pursuant to Rule 14d-2(b) Exchange Act

 

¨ Pre-commencement communications pursuant to Rule 13e-4(c) Exchange Act

 

 

 


Item 5.02 Departure of Directors or Principal Officers; Election of Directors; Appointment of Principal Officers; Compensatory Arrangements of Certain Officers.

(e) As described in Item 5.07 below, USMD Holdings, Inc. (the “Company”) held its 2014 Annual Meeting of Stockholders (the “Annual Meeting”) on June 6, 2014. At the Annual Meeting, the Company’s stockholders approved an amendment to the USMD Holdings, Inc. 2010 Equity Compensation Plan (the “Plan”). The amendment to the Plan had previously been unanimously adopted by the Company’s Board of Directors, subject to stockholder approval at the Annual Meeting.

The Plan allows the Company to grant certain employees (including its principal executive officer, principal financial officer and other named executive officers), consultants, advisors and non-employee directors incentive stock options, nonqualified stock options, stock appreciation rights and restricted stock. Awards are subject to the terms, conditions and limitations of the Plan and as may be determined by the Board of Directors. The amendment approved by the stockholders at the Annual Meeting increased the number of shares of common stock authorized for issuance under the Plan from 1,000,000 to 2,500,000. The amendment to the Plan is attached hereto as Exhibit 10.1.

A description of the material terms of the Plan is set forth in the Company’s definitive proxy statement (the “Proxy Statement”), filed with the Securities and Exchange Commission on April 30, 2014, which description is incorporated herein by reference. The description in the Proxy Statement and the description of the Plan contained herein are qualified in their entirety by reference to the complete Plan.

 

Item 5.07 Submission of Matters to a Vote of Security Holders

(a) The Company held its Annual Meeting on June 6, 2014.

(b) At the Annual Meeting, the Company submitted three proposals, more fully described in the Proxy Statement, to its stockholders for approval. At the Annual Meeting, 9,567,466 shares of common stock were represented in person or by proxy, which constituted 94.3% of the 10,145,634 shares of the Company’s common stock outstanding and entitled to vote at the Annual Meeting as of April 17, 2014, the record date. A brief description of the proposal and the final results of the stockholder vote for each proposal are set forth below.

Proposal 1: The Company’s stockholders elected all eleven director nominees to serve as members of the Company’s board of directors until the Company’s 2015 Annual Meeting of Stockholders or until his or her respective successor has been elected and qualified.

 

Nominee for Director

   For      Withheld      Broker Non-Votes  

John M. House, M.D.

     9,046,083         47,788         473,595   

Steven Brock, M.D.

     9,049,585         44,286         473,595   

Darcie Bundy

     9,084,202         9,669         473,595   

Breaux Castleman

     9,084,202         9,669         473,595   

M. Patrick Collini, M.D.

     9,058,089         35,782         473,595   

Charles Cook, M.D.

     9,084,302         9,569         473,595   

Russell Dickey, M.D.

     9,049,585         44,286         473,595   

Gary Rudin

     9,047,970         45,901         473,595   

James Saalfield, M.D.

     9,058,089         35,782         473,595   

Paul Thompson, M.D.

     9,062,228         31,643         473,595   

Khang Tran, M.D.

     9,043,630         50,241         473,595   


Proposal 2: The Company’s stockholders ratified the appointment of Grant Thornton, L.L.P. as the independent auditor of the Company for the fiscal year ending December 31, 2014.

 

For

  

Against

  

Abstain

  

Broker Non-Votes

9,548,420    18,946    100    473,595

Proposal 3: The Company’s stockholders approved an amendment to the USMD Holdings, Inc. 2010 Equity Compensation Plan.

 

For

  

Against

  

Abstain

  

Broker Non-Votes

8,874,515    219,236    120    473,595

 

Item 9.01 Financial Statements and Exhibits

(d) Exhibits

 

10.1    First Amendment to USMD Holdings, Inc. 2010 Equity Compensation Plan


SIGNATURE

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

 

        USMD HOLDINGS, INC.
Date: June 11, 2014     By:  

/s/ Carolyn Jones

      Carolyn Jones
      Chief Executive Officer